Summary:
A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Reduction with Macupatide and Eloralintide, Alone or in Combination, in Adult Participants with Obesity or Overweight and with Type 2 Diabetes
Qualified Participants Must:
• Have type 2 diabetes
•
Must be overweight
•
Must not be taking Ozempic, Mounjaroo, or similar meds
•
Participants must be 18 to 75 years of age inclusive at the time of signing the informed consent
Qualified Participants May Receive:
Will receive a Stipend, Rideshare, or Mileage reimbursement, and Meals